Clinical Trial: A Clinical Study of Cizutamig in Thyroid Eye Disease

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597200) titled 'A Clinical Study of Cizutamig in Thyroid Eye Disease' on May 13.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with thyroid eye disease (TED).

Study Start Date: May 08

Study Type: INTERVENTIONAL

Condition: Thyroid Eye Disease, TED

Intervention: DRUG: Cizutamig will be dosed according to the protocol.

CND106

Recruitment Status: RECRUITING

Sponsor: Candid Therapeutics

Published by HT Digital Content Services with permission from Health Daily Digest....